Uterine Cavity Assessment and Endometrial Hormonal Receptors in Women With Peri and Post Menopausal Bleeding

• Register: ClinicalTrials.gov
• Last refreshed on: 16 December 2017
• Main ID: NCT02385747
• Date of registration: 03/03/2015
• Prospective Registration: No
• Primary sponsor: Cairo University
• Public title: Uterine Cavity Assessment and Endometrial Hormonal Receptors in Women With Peri and Post Menopausal Bleeding
• Scientific title: Assessment of Uterine Cavity and Endometrial Steroid Receptors in Women With Peri- and Post Menopausal Bleeding
• Date of first enrolment: March 2015
• Target sample size: 100
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02385747
• Study type: Interventional
• Study design: Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Egypt

Contacts

• Name: Ahmed Maged, MD
• Affiliation: Kasr Alainy medical school

Key inclusion & exclusion criteria

Inclusion Criteria:

- women older than 45 years with Abnormal uterine bleeding for more than 3 months
duration

Exclusion Criteria:

- history of hormonal treatment or hormonal contraception within the last 6 months.
Women who had used IUD or those had hysteroscopy or fractional curettage done within
the last 6 months



Age minimum: 45 Years
Age maximum: 65 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Vaginal Bleeding

Intervention(s)

Procedure: hystroscopy

Primary Outcome(s)

detection of endometrial lesion [Time Frame: 2 days after curretage]

Secondary ID(s)

130

Source(s) of Monetary Support

Please refer to primary and secondary sponsors